The Weekly Mind Reader: Smoking Trends in Borderline Personality Disorder Recovery

by Staff Writer
November 10, 2023 at 10:03 AM UTC

This week covers OCD and self-harm, kids showing up in the ER with concurrent psychiatric conditions, and election anxiety.

People with borderline personality disorder (BPD) are 4.1 times more likely to smoke than the average population. This puts them at higher risk for a long list of health problems including cancer, heart disease, stroke, and  lung disease. A new study in The Journal of Clinical Psychiatry examined the influence of recovery on smoking status in this population. 

Methodology and Findings

The study followed 264 patients with BPD over a period of 18 years, collecting and analyzing data at 2-year intervals. Researchers assessed the psychiatric status of the subjects and interviewed them about their smoking histories. 

The findings showed a significant difference in smoking prevalence between those who had recovered and those who had not. At the 6-year follow-up, recovered patients had a 48 percent lower prevalence of smoking compared to non-recovered patients. Furthermore, the study found that the rate of decline in smoking was 68 percent faster among the recovered group compared to those who had not recovered over the course of the study. 

Some distinct patterns emerged. Alcohol abuse or dependence raised the risk of smoking in borderline patients by 22 percent. Having a lower level of education linked to a 28 percent increased chance of smoking. Additionally, using denial as a defense mechanism increased the probability of smoking by a significant eight percent.

The authors offered several theories for why recovery from BPD might help someone kick the habit. 

For one thing, overall cigarette use has steadily declined in the US since the 1940s, in large part due to intense anti-smoking campaigns, targeted quit programs, and higher tobacco prices. People who have recovered from BPD might be more influenced by these changes. For example, they might work in places with smoking bans. 

Recovery also helps people live a healthier lifestyle and enjoy better overall health compared to those who haven’t recovered. Previous research indicates that people with BPD exercise less and require more complex healthcare. They are also prone to serious medical conditions.

Furthermore, people with BPD who haven’t recovered tend to have worse mental health outcomes. They’re more likely to experience dissociation or self-harm, and they tend to struggle with social and work life. This can further erode their physical health and up the risk of early death.

As the researchers noted, these complex factors drive smoking behavior in individuals with BPD. However,  recovery clearly seems to help them give up tobacco. They hope the study’s insights can inform targeted interventions and support strategies to help people with BPD quit smoking.

IN OTHER PSYCHIATRY AND NEUROLOGY NEWS

  • An open-label pilot study of the drug pimavanserin described the subjective improvements of six veterans with active PTSD and chronic insomnia.
  • Capgras syndrome is a delusion of misidentification where a patient believes an individual with whom they are familiar is no longer themselves. A new case study explores the organic cause of this rare but recognizable condition.
  • A new investigation explored the effectiveness of acute short-stay hospital admissions in psychiatric observation units for improving the flow of patients with mental health presentations through the ED.
  • In case you missed it: a specific type of yoga helped reduce depression by nearly 60 percent. Subjects who practiced twice a week enjoyed a 50 percent or greater decrease in depressive symptoms on the IDS-CR scale.
  • The FDA has proposed a ban on brominated vegetable oil (BVO) in response to mounting evidence showing serious neurological risks and thyroid disruption.
  • On our YouTube channel, Jose M. Rubio, MD shares his insights on the predictors for the initiation of atypical long-acting injectable antipsychotics in early-phase schizophrenia.

NEW AT CME INSTITUTE

Click to earn free accredited CME credit.

Cognitive Impairment in Huntington Disease

Comparing LAI and Oral Antipsychotic Options: Expert Discussions with Schizophrenia Case Reports

Commentary

Clinical Implications of Attention-Deficit/Hyperactivity Disorder in Adults: What New Data on Diagnostic Trends, Treatment Barriers, and Telehealth Utilization Tell Us

The authors discuss striking new findings from the Morbidity and Mortality Weekly Report on the burden of adult ADHD, demonstrating the need for the upcoming APSARD Adult ADHD Guidelines.

Gregory Mattingly and others

Letter to the Editor

Measuring Empathy in Artificial Intelligence: Insights From Psychodermatology and Implications for General Practice

The authors assessed which AI modality has the most potential to help a patient with delusional parasitosis based on the Empathy Scale for Human–Computer Communication score.

Kripa Ahuja and others